Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)

Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving more than 300 million people at risk of infection. Of all of the manifestations of this disease, cutaneous leishma...

Full description

Bibliographic Details
Main Authors: Greta Volpedo, Thalia Pacheco-Fernandez, Erin A. Holcomb, Natalie Cipriano, Blake Cox, Abhay R. Satoskar
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.685296/full
_version_ 1818409398617243648
author Greta Volpedo
Greta Volpedo
Thalia Pacheco-Fernandez
Erin A. Holcomb
Natalie Cipriano
Blake Cox
Abhay R. Satoskar
Abhay R. Satoskar
author_facet Greta Volpedo
Greta Volpedo
Thalia Pacheco-Fernandez
Erin A. Holcomb
Natalie Cipriano
Blake Cox
Abhay R. Satoskar
Abhay R. Satoskar
author_sort Greta Volpedo
collection DOAJ
description Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving more than 300 million people at risk of infection. Of all of the manifestations of this disease, cutaneous leishmaniasis (CL) is the most common form and it presents as ulcerating skin lesions that can self-heal or become chronic, leading to disfiguring scars. This review focuses on the different pathologies and disease manifestations of CL, as well as their varying degrees of severity. In particular, this review will discuss self-healing localized cutaneous leishmaniasis (LCL), leishmaniasis recidivans (LR), mucocutaneous leishmaniasis (MCL), anergic diffuse cutaneous leishmaniasis (ADCL), disseminated leishmaniasis (DL), and Post Kala-azar Dermal Leishmaniasis (PKDL), which is a cutaneous manifestation observed in some visceral leishmaniasis (VL) patients after successful treatment. The different clinical manifestations of CL are determined by a variety of factors including the species of the parasites and the host’s immune response. Specifically, the balance between the pro and anti-inflammatory mediators plays a vital role in the clinical presentation and outcome of the disease. Depending upon the immune response, Leishmania infection can also transition from one form of the disease to another. In this review, different forms of cutaneous Leishmania infections and their immunology are described.
first_indexed 2024-12-14T09:59:00Z
format Article
id doaj.art-e77db1be3a724124aa555a619d64a72a
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-14T09:59:00Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-e77db1be3a724124aa555a619d64a72a2022-12-21T23:07:20ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-06-011110.3389/fcimb.2021.685296685296Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)Greta Volpedo0Greta Volpedo1Thalia Pacheco-Fernandez2Erin A. Holcomb3Natalie Cipriano4Blake Cox5Abhay R. Satoskar6Abhay R. Satoskar7Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Microbiology, College of Arts and Sciences, The Ohio State University, Columbus, OH, United StatesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United StatesDepartment of Microbiology, College of Arts and Sciences, The Ohio State University, Columbus, OH, United StatesLeishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving more than 300 million people at risk of infection. Of all of the manifestations of this disease, cutaneous leishmaniasis (CL) is the most common form and it presents as ulcerating skin lesions that can self-heal or become chronic, leading to disfiguring scars. This review focuses on the different pathologies and disease manifestations of CL, as well as their varying degrees of severity. In particular, this review will discuss self-healing localized cutaneous leishmaniasis (LCL), leishmaniasis recidivans (LR), mucocutaneous leishmaniasis (MCL), anergic diffuse cutaneous leishmaniasis (ADCL), disseminated leishmaniasis (DL), and Post Kala-azar Dermal Leishmaniasis (PKDL), which is a cutaneous manifestation observed in some visceral leishmaniasis (VL) patients after successful treatment. The different clinical manifestations of CL are determined by a variety of factors including the species of the parasites and the host’s immune response. Specifically, the balance between the pro and anti-inflammatory mediators plays a vital role in the clinical presentation and outcome of the disease. Depending upon the immune response, Leishmania infection can also transition from one form of the disease to another. In this review, different forms of cutaneous Leishmania infections and their immunology are described.https://www.frontiersin.org/articles/10.3389/fcimb.2021.685296/fullTh1/Th2Cutaneous leishmaniasispost Kala-azar dermal leishmaniasisimmunoregulationimmunopathology
spellingShingle Greta Volpedo
Greta Volpedo
Thalia Pacheco-Fernandez
Erin A. Holcomb
Natalie Cipriano
Blake Cox
Abhay R. Satoskar
Abhay R. Satoskar
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
Frontiers in Cellular and Infection Microbiology
Th1/Th2
Cutaneous leishmaniasis
post Kala-azar dermal leishmaniasis
immunoregulation
immunopathology
title Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
title_full Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
title_fullStr Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
title_full_unstemmed Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
title_short Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
title_sort mechanisms of immunopathogenesis in cutaneous leishmaniasis and post kala azar dermal leishmaniasis pkdl
topic Th1/Th2
Cutaneous leishmaniasis
post Kala-azar dermal leishmaniasis
immunoregulation
immunopathology
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.685296/full
work_keys_str_mv AT gretavolpedo mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl
AT gretavolpedo mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl
AT thaliapachecofernandez mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl
AT erinaholcomb mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl
AT nataliecipriano mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl
AT blakecox mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl
AT abhayrsatoskar mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl
AT abhayrsatoskar mechanismsofimmunopathogenesisincutaneousleishmaniasisandpostkalaazardermalleishmaniasispkdl